PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,505 | -32.8% | 30,500 | +22.0% | 0.01% | -23.5% |
| Q2 2023 | $1,016,750 | -26.4% | 25,000 | -12.3% | 0.02% | -41.4% |
| Q1 2023 | $1,380,540 | +20.6% | 28,500 | -5.0% | 0.03% | +7.4% |
| Q4 2022 | $1,145,100 | +14.1% | 30,000 | +50.0% | 0.03% | +12.5% |
| Q3 2022 | $1,004,000 | -37.3% | 20,000 | -50.0% | 0.02% | -42.9% |
| Q2 2022 | $1,602,000 | +7.4% | 40,000 | 0.0% | 0.04% | +10.5% |
| Q1 2022 | $1,492,000 | -6.3% | 40,000 | 0.0% | 0.04% | +18.8% |
| Q4 2021 | $1,593,000 | +7.1% | 40,000 | 0.0% | 0.03% | +39.1% |
| Q3 2021 | $1,488,000 | -12.0% | 40,000 | 0.0% | 0.02% | -4.2% |
| Q2 2021 | $1,691,000 | -10.7% | 40,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $1,894,000 | -25.3% | 40,000 | -3.8% | 0.02% | -14.3% |
| Q4 2020 | $2,537,000 | +8.5% | 41,572 | -16.9% | 0.03% | -37.8% |
| Q3 2020 | $2,338,000 | +15.2% | 50,000 | +25.0% | 0.04% | -18.2% |
| Q2 2020 | $2,030,000 | +13.8% | 40,000 | 0.0% | 0.06% | -25.7% |
| Q1 2020 | $1,784,000 | -82.4% | 40,000 | -81.0% | 0.07% | -77.6% |
| Q4 2019 | $10,116,000 | +25.4% | 210,611 | -11.7% | 0.33% | +2.8% |
| Q3 2019 | $8,065,000 | -5.7% | 238,455 | +25.4% | 0.32% | +59.4% |
| Q2 2019 | $8,555,000 | +127.3% | 190,118 | +90.1% | 0.20% | +74.1% |
| Q1 2019 | $3,764,000 | +21.9% | 100,000 | +11.1% | 0.12% | -4.9% |
| Q4 2018 | $3,089,000 | -34.3% | 90,000 | -10.0% | 0.12% | +20.8% |
| Q3 2018 | $4,700,000 | +39.3% | 100,000 | 0.0% | 0.10% | +23.2% |
| Q2 2018 | $3,373,000 | -28.8% | 100,000 | -42.9% | 0.08% | -13.7% |
| Q1 2018 | $4,736,000 | +467.9% | 175,000 | +250.0% | 0.10% | +533.3% |
| Q4 2017 | $834,000 | -16.7% | 50,000 | 0.0% | 0.02% | -21.1% |
| Q3 2017 | $1,001,000 | -45.4% | 50,000 | -50.0% | 0.02% | -66.1% |
| Q2 2017 | $1,833,000 | +86.3% | 100,000 | 0.0% | 0.06% | +107.4% |
| Q1 2017 | $984,000 | +80.2% | 100,000 | +100.0% | 0.03% | +50.0% |
| Q4 2016 | $546,000 | -61.0% | 50,000 | -50.0% | 0.02% | -62.5% |
| Q3 2016 | $1,401,000 | -68.7% | 100,000 | +7.5% | 0.05% | -50.5% |
| Q2 2015 | $4,477,000 | +267.9% | 93,000 | +365.0% | 0.10% | +259.3% |
| Q1 2015 | $1,217,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |